I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Martin Garcia-Sancho, Alejandro
387
results:
Search for persons
X
Format
Online (386)
Print (1)
Mediatypes
Articles (Online) (264)
Bookchapter (Online) (9)
OpenAccess-fulltext (113)
Video (DVD/CD) (1)
Languages
german (1)
english (333)
more...
spanish (7)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Lisocabtagene maraleucel in follicular lymphoma: the phase ..:
Morschhauser, Franck
;
Dahiya, Saurabh
;
Palomba, M. Lia
...
Nature Medicine. , 2024
Link:
https://doi.org/10.1038/..
?
2
CD8+ NKs as a potential biomarker of complete response and ..:
Hontecillas-Prieto, Lourdes
;
García-Domínguez, Daniel J.
;
Palazón-Carrión, Natalia
...
Frontiers in Immunology. 15 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
3
Impact of the kinetics of circulating anti-CD19 CAR-T cells..:
Martín-Martín, Lourdes
;
Gutiérrez-Herrero, Sara
;
Herrero-García, María
...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
4
18F-FDG-PET/CT response after first-line treatment as a pro..:
Cordoba, Raul
;
Sánchez-García, Joaquín
;
Domingo-Domenech, Eva
...
Expert Review of Hematology. 17 (2024) 1-3 - p. 95-100 , 2024
Link:
https://doi.org/10.1080/..
?
5
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. ..:
Martín García-Sancho, Alejandro
;
Presa, María
;
Pardo, Carlos
...
Cancers. 16 (2024) 13 - p. 2301 , 2024
Link:
https://doi.org/10.3390/..
?
6
Author Correction: Lisocabtagene maraleucel in follicular l..:
Morschhauser, Franck
;
Dahiya, Saurabh
;
Palomba, M. Lia
...
Nature Medicine. , 2024
Link:
https://doi.org/10.1038/..
?
7
Phase 2 Trial of the Farnesyltransferase Inhibitor Tipifarn..:
Witzig, Thomas E.
;
Sokol, Lubomir
;
Kim, Won Seog
...
Blood Advances. , 2024
Link:
https://doi.org/10.1182/..
?
8
Pembrolizumab in Relapsed or Refractory Primary Mediastinal..:
Zinzani, Pier Luigi
;
Thieblemont, Catherine
;
Melnichenko, Vladimir
...
Blood Journal. , 2023
Link:
https://doi.org/10.1182/..
?
9
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T..:
Bastos-Oreiro, Mariana
;
Gutierrez, Antonio
;
Iacoboni, Gloria
...
Transplantation and Cellular Therapy. 29 (2023) 12 - p. 747.e1-747.e10 , 2023
Link:
https://doi.org/10.1016/..
?
10
P1080: ZANUBRUTINIB PLUS OBINUTUZUMAB VERSUS OBINUTUZUMAB I..:
Trotman, Judith
;
Luigi Zinzani, Pier
;
Mayer, Jiri
...
HemaSphere. 7 (2023) S3 - p. e2687131 , 2023
Link:
https://doi.org/10.1097/..
?
11
Phase 3 SELENE Study: Ibrutinib Plus BR/R-CHOP in Previousl..:
Nastoupil, Loretta J
;
Hess, Georg
;
Pavlovsky, Miguel Arturo
...
Blood Advances. , 2023
Link:
https://doi.org/10.1182/..
?
12
IBRORS-MCL study: a Spanish retrospective and observational..:
Sancho, Juan-Manuel
;
Marín-Niebla, Ana
;
Fernández, Silvia
...
International Journal of Hematology. 116 (2022) 3 - p. 381-392 , 2022
Link:
https://doi.org/10.1007/..
?
13
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Dif..:
Palazón-Carrión, Natalia
;
Martín García-Sancho, Alejandro
;
Nogales-Fernández, Esteban
...
Clinical Cancer Research. 28 (2022) 17 - p. 3658-3668 , 2022
Link:
https://doi.org/10.1158/..
?
14
Open-label, phase 2 study of blinatumomab after frontline R..:
Katz, Deborah A.
;
Morris, Joan D.
;
Chu, Michael P.
...
Leukemia & Lymphoma. 63 (2022) 9 - p. 2063-2073 , 2022
Link:
https://doi.org/10.1080/..
?
15
Best Treatment Option for Patients With Refractory Aggressi..:
Bastos-Oreiro, Mariana
;
Gutierrez, Antonio
;
Reguera, Juan Luís
...
Frontiers in Immunology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
1-15
Related subjects
Horrorfilm, Psychodrame, Thriller